These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23027622)

  • 21. Flow-cytometric DNA content analysis of oesophageal carcinoma. Comparison between tumour and sequential non-tumour mucosae.
    Wang LS; Wu LH; Chang CJ; Li WY; Fahn HJ; Huang MH; Chiu JH
    Scand Cardiovasc J; 1998; 32(4):205-12. PubMed ID: 9802138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
    Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
    Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case of bipartite combined tumour of the oesophagus.
    Goh N; Yeo DXW; Amitbhai SK; Aung MO; Ho YH; Koura AN; Rao J
    World J Surg Oncol; 2019 May; 17(1):79. PubMed ID: 31060613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
    Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
    Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
    van der Doelen MJ; Isaacsson Velho P; Slootbeek PHJ; Pamidimarri Naga S; Bormann M; van Helvert S; Kroeze LI; van Oort IM; Gerritsen WR; Antonarakis ES; Mehra N
    Eur J Cancer; 2020 Sep; 136():16-24. PubMed ID: 32634759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.
    Zhang C; Li K; Wei L; Li Z; Yu P; Teng L; Wu K; Zhu J
    J Clin Pathol; 2007 Nov; 60(11):1249-53. PubMed ID: 17965222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.
    Yasuda M; Kuwano H; Watanabe M; Toh Y; Ohno S; Sugimachi K
    Br J Cancer; 2000 Oct; 83(8):1033-8. PubMed ID: 10993651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    Wallander K; Eisfeldt J; Lindblad M; Nilsson D; Billiau K; Foroughi H; Nordenskjöld M; Liedén A; Tham E
    PLoS One; 2021; 16(2):e0245488. PubMed ID: 33539436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
    Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
    J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
    Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
    Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations.
    Felgentreff K; Schuetz C; Baumann U; Klemann C; Viemann D; Ursu S; Jacobsen EM; Debatin KM; Schulz A; Hoenig M; Schwarz K
    Front Immunol; 2021; 12():739675. PubMed ID: 34594342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
    Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
    Front Immunol; 2021; 12():676922. PubMed ID: 34335575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.
    Uchida S; Shimada Y; Watanabe G; Tanaka H; Shibagaki I; Miyahara T; Ishigami S; Imamura M
    Br J Cancer; 1998 May; 77(10):1704-9. PubMed ID: 9635853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
    Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
    Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.
    Schepeler T; Lamy P; Hvidberg V; Laurberg JR; Fristrup N; Reinert T; Bartkova J; Tropia L; Bartek J; Halazonetis TD; Pan CC; Borre M; Dyrskjøt L; Orntoft TF
    Oncogene; 2013 Aug; 32(31):3577-86. PubMed ID: 22926521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.
    Fu L; Zhang C; Zhang LY; Dong SS; Lu LH; Chen J; Dai Y; Li Y; Kong KL; Kwong DL; Guan XY
    Gut; 2011 Dec; 60(12):1635-43. PubMed ID: 21672941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RECQL4 regulates DNA damage response and redox homeostasis in esophageal cancer.
    Lyu G; Su P; Hao X; Chen S; Ren S; Zhao Z; Gong Y; Liu Q; Shao C
    Cancer Biol Med; 2021 Feb; 18(1):120-138. PubMed ID: 33628589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
    Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
    Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.